Laxi Herb and Pregnancy Constipation

Investigating Effect of Laxi Herb Syrup To Relieve Constipation In Pregnant Women Treated with Ondansetron

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241118063767N3

Enrollment

Registered

2024-12-18

Start date

2025-01-04

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation. Functional intestinal disorder, unspecified

Interventions

Intervention 1: Intervention group: Taking Ondansetron and Laxiherb syrup from Barij Essence Company, consisting of red plum and brown sugar, 2 cups, 5 ml, 3 times a day. Intervention 2: Control group

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Consent to participate in the study Pregnancy with Ondansetron use

Exclusion criteria

Exclusion criteria: History of hemorrhoids Allergy to plum and brown sugar compounds Blood sugar disorder and diabetes

Design outcomes

Primary

Measure	Time frame
Number of discharges. Timepoint: At the beginning of the study and 14 days after the intervention. Method of measurement: ROME III Irritable Bowel Syndrome Gastrointestinal Symptoms Assessment Questionnaire.;Feeling incomplete discharge. Timepoint: At the beginning of the study and 14 days after the intervention. Method of measurement: ROME III Irritable Bowel Syndrome Gastrointestinal Symptoms Assessment Questionnaire.;Anal ulcer. Timepoint: At the beginning of the study and 14 days after the intervention. Method of measurement: ROME III Irritable Bowel Syndrome Gastrointestinal Symptoms Assessment Questionnaire.	—

Measure

Time frame

Number of discharges. Timepoint: At the beginning of the study and 14 days after the intervention. Method of measurement: ROME III Irritable Bowel Syndrome Gastrointestinal Symptoms Assessment Questionnaire.;Feeling incomplete discharge. Timepoint: At the beginning of the study and 14 days after the intervention. Method of measurement: ROME III Irritable Bowel Syndrome Gastrointestinal Symptoms Assessment Questionnaire.;Anal ulcer. Timepoint: At the beginning of the study and 14 days after the intervention. Method of measurement: ROME III Irritable Bowel Syndrome Gastrointestinal Symptoms Assessment Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansooreh Sadat Mojani Qomi

Islamic Azad University

mansooreh.moujani@gmail.com+98 21 2264 0052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026